A study in 2013 comparing the diagnostic performance of CRP, PCT, TNF-alpha, IL-6 demonstrated that CRP at day 1 fared better than other biomarkers at identifying pneumonic exacerbations in COPD [22]. This evidence concerns the gene TNF and chronic obstructive pulmonary disease.